Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD001011

Type of data
NGS (Exome, RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
276 GB
File formats
  • FASTQ
Research
hum0342
Date published
2026-01-06
Date modified
2026-04-15

Analysis method

WES

Materials and participants
Small intestine cancer (ICD10: C17): 11 cases
tumor and non-tumor tissue pairs: total 22 samples
  • Health status
    Affected
  • Subject count
    11 (Individual)
Disease
Small intestine cancer (C17)
Sample description
DNAs extracted from tumor and non-tumor tissues
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
Exome2.0 plus Comprehensive Exome Spike-in
Twist Comprehensive Exome Panel
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp

RNA-seq

Materials and participants
Small intestine cancer (ICD10: C17): 15 cases (4 cases are also used in Exome)
tumor tissues: 10 samples, non-tumor tissues: 5 samples
  • Health status
    Affected
  • Subject count
    15 (Individual)
Disease
Small intestine cancer (C17)
Sample description
RNAs extracted from tumor and non-tumor tissues
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
SMART-Seq Stranded Kit
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp